Patents by Inventor Vincent Ellis
Vincent Ellis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8311857Abstract: A system for preventing fraud is disclosed as is a method of performing the same. Information is received by the system and a database is created containing personal information of deceased individuals. The system then interacts with a billing system to prevent the information of a deceased individual present in the database from being used to submit a false claim.Type: GrantFiled: December 24, 2010Date of Patent: November 13, 2012Inventor: Vincent Ellis Hill
-
Publication number: 20120166227Abstract: A system for preventing fraud is disclosed as is a method of performing the same. Information is received by the system and a database is created containing personal information of deceased individuals. The system then interacts with a billing system to prevent the information of a deceased individual present in the database from being used to submit a false claim.Type: ApplicationFiled: December 24, 2010Publication date: June 28, 2012Inventor: Vincent Ellis Hill
-
Publication number: 20080166354Abstract: The present invention relates to methods for inhibiting malignant tumour growth, invasion and/or metastasis in a patient, the method comprising suppressing the inhibitory activity of an inhibitor of a protease or of a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumour tissue or potential malignant tumour tissue. The suppression may be brought about by administering compounds interacting with the IPNME, but also administration of compounds interacting with transcription of genes encoding the IPNME is a possibility. The invention also relates to methods of selecting and identifying compounds in the therapeutical methods, as well of the use of such compounds in the treatment of malignancies.Type: ApplicationFiled: December 26, 2007Publication date: July 10, 2008Inventors: Niels Brunner, John Romer, Vincent Ellis, Charles Pyke, Jan Grondahl-Hansen, Helle Pedersen Pappot, Heine Hoi Hansen, Keld Dano
-
Publication number: 20070054651Abstract: A cordless electronic device with power management system and method is provided that includes an outer surface, a power consumption circuit operable to consume power and for use in a cordless electronic device, a power supply circuit operable to regulate the power from a power source used to power the power consumption circuit of the cordless electronic device, a power control circuit operable to receive an input signal and to place the power consumption circuit in a lower or higher power state upon receipt of the input signal, a presence sensor operable to detect the presence of a user and to provide a presence sensor input signal to the power control circuit to place the power consumption circuit in the higher power state.Type: ApplicationFiled: September 6, 2006Publication date: March 8, 2007Applicant: AMX, LLCInventors: Michael Farmer, Vincent Ellis, Kenneth Carpenter
-
Publication number: 20030096755Abstract: The present invention relates to methods for inhibiting malignant tumour growth, invasion and/or metastasis in a patient, the method comprising suppressing the inhibitory activity of an inhibitor of a protease or of a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumour tissue or potential malignant tumour tissue. The suppression may be brought about by administering compounds interacting with the IPNME, but also administration of compounds interacting with transcription of genes encoding the IPNME is a possibility. The invention also relates to methods of selecting and identifying compounds in the therapeutical methods, as well of the use of such compounds in the treatment of malignancies.Type: ApplicationFiled: January 2, 2003Publication date: May 22, 2003Inventors: Niels Brunner, John Romer, Vincent Ellis, Charles Pyke, Jan Grondahl-Hansen, Helle Pedersen Pappot, Heine Hoi Hansen, Keld Dano
-
Publication number: 20030027981Abstract: A polypeptide presenting an epitope cross-reactive with an epitope of urokinase-type plasminogen activator receptor, and/or having uPA binding activity, is described.Type: ApplicationFiled: January 8, 2001Publication date: February 6, 2003Inventors: Keld Dano, Francesco Blasi, Ann Louring Roldan, Maria Vittoria Cubellis, Maria Teresa Masucci, Ettore Appella, Wolf-Dieter Schleuning, Niels Behrendt, Ebbe Ronne, Peter Kristensen, Jari Pollanen, Eeva-Marjatta Salonen, Ross W. Stephens, Hannele Tapiovaara, Antti Vaheri, Lisbeth Birk Moller, Vincent Ellis, Leif Roge Lund, Michael Ploug, Charles Pyke, Laszlo Patthy
-
Publication number: 20010034327Abstract: The present invention relates to methods for inhibiting malignant tumour growth, invasion and/or metastasis in a patient, the method comprising suppressing the inhibitory activity of an inhibitor of a protease or of a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumour tissue or potential malignant tumour tissue. The suppression may be brought about by administering compounds interacting with the IPNME, but also administration of compounds interacting with transcription of genes encoding the IPNME is a possibility. The invention also relates to methods of selecting and identifying compounds in the therapeutical methods, as well of the use of such compounds in the treatment of malignancies.Type: ApplicationFiled: April 18, 2001Publication date: October 25, 2001Inventors: Niels Brunner, John Romer, Vincent Ellis, Charles Pyke, Jan Grondahl-Hansen, Helle Pedersen Pappot, Heine Hoi Hansen, Keld Dano
-
Patent number: 6248712Abstract: Activation of plasminogen to plasmin is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type plasminogen activator from converting plasminogen into plasmin. DNA fragments which encode for soluble, active fragments of the urokinase-type plasminogen activator receptor are provided.Type: GrantFiled: May 16, 1995Date of Patent: June 19, 2001Assignee: Cancerforskningsfondet af 1989Inventors: Keld Danø, Francesco Blasi, Ann Louring Roldan, Maria Vittoria Cubellis, Maria Teresa Masucci, Ettore Appella, W.D. Schleuning, Niels Behrendt, Ebbe Rønne, Peter Kristensen, Jari Pöllänen, Eeva-Marjatta Salonen, Ross W. Stephens, Hannele Tapiovaara, Antti Vaheri, Lisbeth Birk Møller, Vincent Ellis, Leif Røge Lund, Michael Ploug, Charles Pyke, Lászl{acute over (o )} Patthy
-
Patent number: 6224865Abstract: The present invention relates to methods for inhibiting malignant tumour growth, invasion and/or metastasis in a patient, the method comprising suppressing the inhibitory activity of an inhibitor of a protease or of a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumour tissue or potential malignant tumour tissue. The suppression may be brought about by administering compounds interacting with the IPNME, but also administration of compounds interacting with transcription of genes encoding the IPNME is a possibility. The invention also relates to methods of selecting and identifying compounds in the therapeutical methods, as well of the use of such compounds in the treatment of malignancies.Type: GrantFiled: May 15, 1996Date of Patent: May 1, 2001Assignee: Cancerforskningsfonden AF 1989Inventors: Nils Brünner, John Rømer, Vincent Ellis, Charles Pyke, Jan Grøndahl-Hansen, Helle Pedersen, Heine Høi Hansen, Keld Danø
-
Patent number: 6113897Abstract: A monoclonal or polyclonal antibody directed against urokinase plasminogen activator receptor (u-PAR), or a subsequence, analogue or glycosylation variant thereof. Antibodies are disclosed which react with free u-PAR or with complexes between u-PA and u-PAR and which are capable of 1) catching u-PAR in ELISA, or 2) detecting u-PAR, e.g. in blotting, or 3) in radioimmunoprecipitation assay precipitate purified u-PAR in intact or fragment form, or 4) is useful for immunohistochemical detection of u-PAR, e.g. in immunostaining of cancer cells, such as in tissue sections at the invasive front, or 5) inhibits the binding of pro-u-PA and active u-PA and thereby inhibits cell surface plasminogen activation. Methods are disclosed 1) for detecting or quantifying u-PAR, 2) for targeting a diagnostic to a cell containing a u-PAR on the surface, 3) for preventing or counteracting proteolytic activity in a mammal.Type: GrantFiled: December 28, 1995Date of Patent: September 5, 2000Assignee: Cancerforskiningsfonden af 1989Inventors: Keld Dan.o slashed., Ebbe R.o slashed.nne, Niels Behrendt, Vincent Ellis, Gunilla H.o slashed.yer-Hansen, Charles Pyke, Nils Bruenner
-
Patent number: 6025142Abstract: The invention relates to an antibody which inhibits the binding between u-PA and u-PAR to an extent of at least 90% in an assay as defined in the specification, or an active fragment or immunological equivalent of said antibody. Examples of such antibodies are deposited Jul. 7, 1994 at Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSM) with accession numbers DSM ACC2178 and DSM ACC2179 under the terms and conditions of the Budapest Treaty. The invention furthermore relates to a method for detecting or quantifying u-PAR or a glycosylation variant of u-PAR in a sample by use of an antibody according to the invention.Furthermore, the invention relates to a method for the manufacture of a therapeutic agent for preventing or counteracting localized proteolytic activity using of an antibody of the invention as well as to use of an antibody according to the invention for the preparation of a diagnostic agent which is capable of targeting a diagnostic to a cell that contains a u-PAR on the surface.Type: GrantFiled: June 2, 1995Date of Patent: February 15, 2000Assignees: Boehringer Mannheim GmbH, Cancerforskningsfonden af 1989Inventors: Ulrich Pessara, Ulrich Weidle, Bernhard Konig, Ulrich Kohnert, Ilse Bartke, Keld Dan.o slashed., Michael Ploug, Vincent Ellis
-
Patent number: 5903518Abstract: An acoustic impulse source has been developed and used to simulate the high coustic output of detonation driven acoustic sources. While detonation driven acoustic sources are capable of producing large acoustic signals (>160 dB) at 10s and 100s of meters from the source, their laboratory use is limited due to the combustion byproducts. The present invention is capable of reproducing the downrange detonative source acoustic signals (170 dB) at short range, on the order of 1 meter, without noxious or large thermal byproducts. The present invention relies on the plasma formation resulting from electrical arc discharge in air to generate thermal impulses and the resultant acoustic signals. Utilizing multiple plasma channels and timing control of the formation of said channels, the present invention achieves increased efficiency and the ability to tailor the acoustic output signal to match the desired detonation source characteristic output.Type: GrantFiled: February 23, 1998Date of Patent: May 11, 1999Assignee: The United States of America as represented by the Secretary of the ArmyInventors: Bruce Benwell, Dave DeTroye, Harold E. Boesch, Vincent Ellis
-
Patent number: 5891664Abstract: Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type plasminogen activator from converting plasminogen into plasmin. DNA fragments which encode for soluble, active fragments of the urokinase-type plasminogen activator are provided.Type: GrantFiled: October 6, 1994Date of Patent: April 6, 1999Assignee: Cancerforskningsfondet af 1989Inventors: Keld Dan.o slashed., Francesco Blasi, Ann Louring Roldan, Maria Vittoria Cubellis, Maria Teresa Masucci, Ettore Appella, Wolf-Dieter Schleuning, Niels Behrendt, Ebbe R.o slashed.nne, Peter Kristensen, Jari Pollanen, Eeva-Marjatta Salonen, Ross W. Stephens, Hannele Tapiovaara, Antti Vaheri, Lisbeth Birk M.o slashed.ller, Vincent Ellis, Leif R.o slashed.ge Lund, Michael Ploug, Charles Pyke, Laszlo Patthy
-
Patent number: 5519120Abstract: A monoclonal or polyclonal antibody directed against urokinase plasminogen activator receptor (u-PAR), or a subsequence, analogue or glycosylation variant thereof. Antibodies are disclosed which react with free u-PAR or with complexes between u-PA and u-PAR and which are capable of 1) catching u-PAR in ELISA, or 2) detecting u-PAR, e.g. in blotting, or 3) in radioimmunoprecipitation assay precipitate purified u-PAR in intact or fragment form, or 4) is useful for immunohistochemical detection of u-PAR, e.g. in immunostaining of cancer cells, such as in tissue sections at the invasive front, or 5) inhibits the binding of pro-u-PA and active u-PA and thereby inhibits cell surface plasminogen activation. Methods are disclosed 1) for detecting or quantifying u-PAR, 2) for targeting a diagnostic to a cell containing a u-PAR on the surface, 3) for preventing or counteracting proteolytic activity in a mammal.Type: GrantFiled: June 17, 1993Date of Patent: May 21, 1996Assignee: Cancerforskningsfondet af 1989Inventors: Keld Dano, Ebbe Ronne, Niels Behrendt, Vincent Ellis, Gunilla Hoyer-Hansen, Charles Pyke, Nils Bruenner
-
Patent number: H1832Abstract: An electromagnetically transparent fluidic operator for adapting a conventional, mechanically operated electric switch to remote, fluidic operation includes a non-metallic housing for being rigidly attached to the electric switch with a chamber in the housing aligned with a mechanical actuator of the electric switch and a non-metallic, expandable reservoir mounted by the housing. The reservoir includes a nipple rigidly attached to the housing and a deformable diaphragm forming a seal with the nipple and being disposed in the chamber close to the mechanical actuator. The reservoir is pressurized with fluid from a remote location causing the diaphragm to deform and the reservoir to expand thereby applying a positive pressure or operating force against the mechanical actuator to operate the electric switch.Type: GrantFiled: June 3, 1996Date of Patent: February 1, 2000Assignee: The United States of America as represented by the Secretary of the ArmyInventor: Vincent Ellis